| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $74.9M | -51.5% | +29.8% |
| Cost of Revenue | $79.2M | -21.3% | +62.3% |
| Gross Profit | -$4.3M | -108.0% | -148.3% |
| R&D Expense | $1.7M | -48.5% | -58.5% |
| SG&A Expense | $8.9M | -3.3% | -11.0% |
| Operating Income | -$16.6M | -149.6% | -118.4% |
| Interest Expense | $3.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.63B | +95.9% | +739.8% |
| Accounts Receivable | $60.7M | +93.9% | +217.8% |
| Inventory | $416.3M | +29.9% | +118.3% |
| Current Assets | $2.16B | +73.1% | +318.8% |
| Total Assets | $2.24B | +70.7% | +279.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $99.4M | — | — |
| Capital Expenditures | $10.1M | — | — |
| Investing Cash Flow | -$10.1M | — | — |
| Financing Cash Flow | $841.4M | — | — |
| Free Cash Flow | $89.3M | — | — |
| +9.7% |
| +3300.0% |
| Pre-tax Income | -$8.0M | -121.4% | -35.6% |
| Income Tax | -$11.9M | -240.0% | -1222.2% |
| Net Income | $3.9M | -86.5% | +178.0% |
| EPS (Basic) | $0.21 | -87.1% | +170.0% |
| EPS (Diluted) | $0.19 | -88.1% | +163.3% |
| $626.2M |
| +29.9% |
| +97.6% |
| Long-term Debt | $1.17B | +200.9% | +1305.4% |
| Total Liabilities | $1.88B | +96.9% | +265.7% |
| Stockholders' Equity | $363.1M | +1.1% | +375.3% |